20|20 OptimEyes Technologies
Founded 2018
About 20|20 OptimEyes Technologies
20/20 OptimEyes Technologies is a biotechnology company specializing in ocular drug delivery methods. The company has developed a proprietary mucoadhesive drug delivery platform that enhances the solubility of active pharmaceutical ingredients (APIs). This technology aims to improve the treatment of ocular diseases by providing a more effective and sustained release of medication. The interdisciplinary team at 20/20 OptimEyes Technologies includes experts in polymer and biomaterial engineering, chemistry, pharmaceutical formulation, and drug delivery systems.
Company Facts
- Founded: 2018
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Website: 2020optimeyes.ca
- Phone: 1 (905) 978-9262
Social Profiles
Canonical: https://fsome.com/organization/20-20-optimeyes-technologies-8394411 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.